Inhibition of replication of HIV in primary monocyte/macrophages by different antiviral drugs and comparative efficacy in lymphocytes

被引:63
作者
Aquaro, S
Perno, CF
Balestra, E
Balzarini, J
Cenci, A
Francesconi, M
Panti, S
Serra, F
Villani, N
Calio, R
机构
[1] UNIV ROMA TOR VERGATA, DEPT EXPT MED & BIOCHEM SCI, I-00135 ROME, ITALY
[2] CATHOLIC UNIV LEUVEN, REGA INST MED RES, B-3000 LOUVAIN, BELGIUM
[3] FRASCATI HOSP, HAEMATOL CTR, FRASCATI, ITALY
关键词
anti-viral therapy; AIDS; reverse transcriptase inhibitors; cytokines; non-nucleoside reverse transcriptase inhibitor; protease inhibitors;
D O I
10.1002/jlb.62.1.138
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Several anti-HIV drugs acting on different steps of virus replication were tested in our experimental model of primary monocyte/macrophages; the results were compared with the activity found in lymphocytes, Nucleoside analogues (AZT, ddI, ddC, d4T, PMEA, 3TC etc.) show greater,activity in macrophages (M/M) than in lymphocytes. In particular, the EC50 of AZT, ddC, and ddI in M/M is 2- to 100-fold lower than that found in lymphocytes, This greater efficacy of nucleoside analogues in M/M depends on the enhancement of their chain-terminating activity by the low levels of endogenous deoxynucleoside-triphosphates (dNTP) usually found in resting cells such as MN, Nonnucleoside reverse transcriptase inhibitors (NNRTI) do not act as chain terminators (thus their antiviral effect is not related to the intracellular concentrations of dNTP); as a consequence the activity of TSAO, HEPT, TIBO, and other NNRTI tested in M/M is similar to that found in lymphocytes. Regarding inhibitors of binding and fusion of HN; we found that their anti-HIV activity is markedly decreased (or even nullified) when M/M are treated with cytokine activators of M/M function and enhancers of HIV replication, More relevant from a clinical standpoint, protease inhibitors are able to inhibit HIV replication in chronically infected macrophages (i.e., cells carrying the proviral genome already integrated in the host genome), All other inhibitors of late stage of virus life cycle tested (antisense-rev, anti-tat, interferon-alpha and -gamma, phosphorothioate analogues, GLQ-223, etc.) were totally inactive in chronically infected macrophages, The different effects of various classes of HIV inhibitors in lymphocytes and macrophages suggests that AIDS therapy should consider all aspects of the pathogenesis of HIV infection and must be restricted to drugs, or combinations of drugs, active against both lymphocytes and M/M in all body compartments where the virus hides and replicates.
引用
收藏
页码:138 / 143
页数:6
相关论文
共 40 条
  • [1] Dynamics and modulation of human immunodeficiency virus type 1 transcripts in vitro and in vivo
    Bagnarelli, P
    Valenza, A
    Menzo, S
    Sampaolesi, R
    Varaldo, PE
    Butini, L
    Montroni, M
    Perno, CF
    Aquaro, S
    Mathez, D
    Leibowitch, J
    Balotta, C
    Clementi, M
    [J]. JOURNAL OF VIROLOGY, 1996, 70 (11) : 7603 - 7613
  • [2] Balzarini J, 1996, MOL PHARMACOL, V50, P394
  • [3] Activity of the (R)-enantiomers of 9-(2-phosphonylmethoxypropyl)-adenine and 9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine against human immunodeficiency virus in different human cell systems
    Balzarini, J
    Aquaro, S
    Perno, CF
    Witvrouw, M
    Holy, A
    DeClercq, E
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 219 (02) : 337 - 341
  • [4] ISOLATION OF A T-LYMPHOTROPIC RETROVIRUS FROM A PATIENT AT RISK FOR ACQUIRED IMMUNE-DEFICIENCY SYNDROME (AIDS)
    BARRESINOUSSI, F
    CHERMANN, JC
    REY, F
    NUGEYRE, MT
    CHAMARET, S
    GRUEST, J
    DAUGUET, C
    AXLERBLIN, C
    VEZINETBRUN, F
    ROUZIOUX, C
    ROZENBAUM, W
    MONTAGNIER, L
    [J]. SCIENCE, 1983, 220 (4599) : 868 - 871
  • [5] BERGAMINI A, 1994, BLOOD, V84, P3405
  • [6] STIMULATION AND INHIBITION BY NORMAL HUMAN SERUM OF COLONY FORMATION IN-VITRO BY BONE MARROW CELLS
    CHAN, SH
    METCALF, D
    STANLEY, ER
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1971, 20 (03) : 329 - &
  • [7] CUMMINS LM, 1991, BLOOD, V77, P1111
  • [8] HIGHLY POTENT AND SELECTIVE-INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS BY THE BICYCLAM DERIVATIVE JM3100
    DE CLERCQ, E
    YAMAMOTO, N
    PAUWELS, R
    BALZARINI, J
    WITVROUW, M
    DEVREESE, K
    DEBYSER, Z
    ROSENWIRTH, B
    PEICHL, P
    DATEMA, R
    THORNTON, D
    SKERLJ, R
    GAUL, F
    PADMANABHAN, S
    BRIDGER, G
    HENSON, G
    ABRAMS, M
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (04) : 668 - 674
  • [9] DeClercq E, 1996, MED RES REV, V16, P125, DOI 10.1002/(SICI)1098-1128(199603)16:2<125::AID-MED1>3.0.CO
  • [10] 2-2